Increase in Funding
NIH funding to the Sanders-Brown Center on Aging increased from $13.3 million to $23.4 million in one year, a remarkable 75% increase in funding.
Beginning with only three faculty members, the Center has grown to more than 125 employees and to be one of the nation's leading centers on aging.
Card image

Drug studied at UK is first disease-modifying therapy in U.S. approved to treat Alzheimer’s

On July 6, 2023, the U.S. Food and Drug Administration (FDA) granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer’s disease. The University of Kentucky’s Sanders-Brown Center on Aging has been working with this drug and others like it for more than a decade.

Card image

Mind Matters Magazine

Read the latest edition of the Mind Matters Magazine!